Cargando…

The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability

PURPOSE: The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI) is a method for assessing the likelihood that a patient’s muscle symptoms (e.g., myalgia or myopathy) were caused or worsened by statin use. The objectives of this study were to prepare the SAMS-CI for clinical use, estimate its...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenson, Robert S, Miller, Kate, Bayliss, Martha, Sanchez, Robert J, Baccara-Dinet, Marie T, Chibedi-De-Roche, Daniela, Taylor, Beth, Khan, Irfan, Manvelian, Garen, White, Michelle, Jacobson, Terry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427100/
https://www.ncbi.nlm.nih.gov/pubmed/28421332
http://dx.doi.org/10.1007/s10557-017-6723-4
_version_ 1783235600426467328
author Rosenson, Robert S
Miller, Kate
Bayliss, Martha
Sanchez, Robert J
Baccara-Dinet, Marie T
Chibedi-De-Roche, Daniela
Taylor, Beth
Khan, Irfan
Manvelian, Garen
White, Michelle
Jacobson, Terry A.
author_facet Rosenson, Robert S
Miller, Kate
Bayliss, Martha
Sanchez, Robert J
Baccara-Dinet, Marie T
Chibedi-De-Roche, Daniela
Taylor, Beth
Khan, Irfan
Manvelian, Garen
White, Michelle
Jacobson, Terry A.
author_sort Rosenson, Robert S
collection PubMed
description PURPOSE: The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI) is a method for assessing the likelihood that a patient’s muscle symptoms (e.g., myalgia or myopathy) were caused or worsened by statin use. The objectives of this study were to prepare the SAMS-CI for clinical use, estimate its inter-rater reliability, and collect feedback from physicians on its practical application. METHODS: For content validity, we conducted structured in-depth interviews with its original authors as well as with a panel of independent physicians. Estimation of inter-rater reliability involved an analysis of 30 written clinical cases which were scored by a sample of physicians. A separate group of physicians provided feedback on the clinical use of the SAMS-CI and its potential utility in practice. RESULTS: Qualitative interviews with providers supported the content validity of the SAMS-CI. Feedback on the clinical use of the SAMS-CI included several perceived benefits (such as brevity, clear wording, and simple scoring process) and some possible concerns (workflow issues and applicability in primary care). The inter-rater reliability of the SAMS-CI was estimated to be 0.77 (confidence interval 0.66–0.85), indicating high concordance between raters. With additional provider feedback, a revised SAMS-CI instrument was created suitable for further testing, both in the clinical setting and in prospective validation studies. CONCLUSIONS: With standardized questions, vetted language, easily interpreted scores, and demonstrated reliability, the SAMS aims to estimate the likelihood that a patient’s muscle symptoms were attributable to statins. The SAMS-CI may support better detection of statin-associated muscle symptoms in clinical practice, optimize treatment for patients experiencing muscle symptoms, and provide a useful tool for further clinical research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10557-017-6723-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5427100
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-54271002017-05-26 The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability Rosenson, Robert S Miller, Kate Bayliss, Martha Sanchez, Robert J Baccara-Dinet, Marie T Chibedi-De-Roche, Daniela Taylor, Beth Khan, Irfan Manvelian, Garen White, Michelle Jacobson, Terry A. Cardiovasc Drugs Ther Original Article PURPOSE: The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI) is a method for assessing the likelihood that a patient’s muscle symptoms (e.g., myalgia or myopathy) were caused or worsened by statin use. The objectives of this study were to prepare the SAMS-CI for clinical use, estimate its inter-rater reliability, and collect feedback from physicians on its practical application. METHODS: For content validity, we conducted structured in-depth interviews with its original authors as well as with a panel of independent physicians. Estimation of inter-rater reliability involved an analysis of 30 written clinical cases which were scored by a sample of physicians. A separate group of physicians provided feedback on the clinical use of the SAMS-CI and its potential utility in practice. RESULTS: Qualitative interviews with providers supported the content validity of the SAMS-CI. Feedback on the clinical use of the SAMS-CI included several perceived benefits (such as brevity, clear wording, and simple scoring process) and some possible concerns (workflow issues and applicability in primary care). The inter-rater reliability of the SAMS-CI was estimated to be 0.77 (confidence interval 0.66–0.85), indicating high concordance between raters. With additional provider feedback, a revised SAMS-CI instrument was created suitable for further testing, both in the clinical setting and in prospective validation studies. CONCLUSIONS: With standardized questions, vetted language, easily interpreted scores, and demonstrated reliability, the SAMS aims to estimate the likelihood that a patient’s muscle symptoms were attributable to statins. The SAMS-CI may support better detection of statin-associated muscle symptoms in clinical practice, optimize treatment for patients experiencing muscle symptoms, and provide a useful tool for further clinical research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10557-017-6723-4) contains supplementary material, which is available to authorized users. Springer US 2017-04-18 2017 /pmc/articles/PMC5427100/ /pubmed/28421332 http://dx.doi.org/10.1007/s10557-017-6723-4 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Rosenson, Robert S
Miller, Kate
Bayliss, Martha
Sanchez, Robert J
Baccara-Dinet, Marie T
Chibedi-De-Roche, Daniela
Taylor, Beth
Khan, Irfan
Manvelian, Garen
White, Michelle
Jacobson, Terry A.
The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
title The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
title_full The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
title_fullStr The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
title_full_unstemmed The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
title_short The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
title_sort statin-associated muscle symptom clinical index (sams-ci): revision for clinical use, content validation, and inter-rater reliability
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427100/
https://www.ncbi.nlm.nih.gov/pubmed/28421332
http://dx.doi.org/10.1007/s10557-017-6723-4
work_keys_str_mv AT rosensonroberts thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT millerkate thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT baylissmartha thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT sanchezrobertj thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT baccaradinetmariet thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT chibediderochedaniela thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT taylorbeth thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT khanirfan thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT manveliangaren thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT whitemichelle thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT jacobsonterrya thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT rosensonroberts statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT millerkate statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT baylissmartha statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT sanchezrobertj statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT baccaradinetmariet statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT chibediderochedaniela statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT taylorbeth statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT khanirfan statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT manveliangaren statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT whitemichelle statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability
AT jacobsonterrya statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability